Clinical trial
Assessment of Equivalence of a Non-invasive In-vitro Diagnostic Test (Peptest) in Comparison to Other Routine Clinical Diagnostic Methods for GERD by Testing a Large Number of Clinical Samples
NCT02456779 is registered in ClinicalTrials.gov with MAAB (Shanghai) Medical Device Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Equivalence of a Non-invasive In-vitro Diagnostic Test (Peptest) in Comparison to Other Routine Clinical Diagnostic Methods for GERD by Testing a Large Number of Clinical Samples
- Lead sponsor
- MAAB (Shanghai) Medical Device Limited
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- November 30, 2017
- Enrollment
- 1,032 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
gastro-esophageal reflux disease